HomeInsightsStock Comparison

Dr Lal Pathlabs Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Dr Lal Pathlabs Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Last Updated on: Jun 06, 2025

Key Highlights

  • The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 2849 as of 06 Jun 15:30.
  • The P/E Ratio of Dr Lal Pathlabs Ltd changed from 51.7 on March 2020 to 42.5 on March 2025 . This represents a CAGR of -3.21% over 6 yearsThe P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 11679 crore on March 2020 to ₹ 20714 crore on March 2025 . This represents a CAGR of 10.02% over 6 yearsThe Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 628.4 crore as compare to the Dec '24 revenue of ₹ 621.8 crore. This represent the growth of 1.06% The revenue of Lotus Eye Hospital & Institute Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 194.8 crore as compare to the Dec '24 ebitda of ₹ 179.1 crore. This represent the growth of 8.77% The ebitda of Lotus Eye Hospital & Institute Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Dr Lal Pathlabs Ltd changed from ₹ 83.6 crore to ₹ 155.5 crore over 8 quarters. This represents a CAGR of 36.38% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Dr Lal Pathlabs Ltd changed from 49.24 % on March 2020 to 40.34 % on March 2025 . This represents a CAGR of -3.27% over 6 yearsThe Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Lal Pathlabs Ltd

  • Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
  • The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
  • The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
  • Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Lotus Eye Hospital & Institute Ltd

  • Lotus Eye Hospital & Institute Ltd, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
  • Limited' on 14 March, 1997.
  • The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
  • Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013.
  • Dr S.K.Sundaramoorthy promoted the Company. Lotus Eye Care Hospital is the state of art eye care hospital group successfully functioning in South India with specialization in super-specialty service related to eye care.

Dr Lal Pathlabs Ltd News Hub

News

Board of Dr. Lal PathLabs recommends final dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs to convene AGM

Dr. Lal PathLabs announced that the Annual General Meeting(AGM) of the company will be hel...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs schedules board meeting

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 25 April ...

Read more

19 Apr 2025 10:39

News

Dr Lal Pathlabs introduces highly specialized Amyloidosis test

Dr Lal Pathlabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spec...

Read more

15 Apr 2025 14:09

News

Dr Lal Pathlabs Ltd leads losers in 'A' group

Aditya Birla Real Estate Ltd, Can Fin Homes Ltd, Paisalo Digital Ltd and Religare Enterpri...

Read more

25 Feb 2025 15:00

News

Dr Lal Pathlabs allots 4,000 equity shares under ESOP

Dr Lal Pathlabs has allotted 4,000 equity shares under ESOP on 18 February 2025. With this...

Read more

18 Feb 2025 18:20

Lotus Eye Hospital & Institute Ltd News Hub

News

Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Compan...

Read more

23 May 2025 17:44

News

Lotus Eye Hospital & Institute Ltd leads gainers in 'B' group

Country Condos Ltd, Hexa Tradex Ltd, Jagsonpal Pharmaceuticals Ltd and SEL Manufacturing C...

Read more

25 Apr 2025 12:15

News

Lotus Eye Hospital & Institute to discuss results

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Compan...

Read more

04 Nov 2024 15:13

News

Lotus Eye Hospital & Institute to convene AGM

Lotus Eye Hospital & Institute announced that the 27th Annual General Meeting (AGM) of the...

Read more

23 Jul 2024 20:10

News

Lotus Eye Hospital & Institute Ltd leads losers in 'B' group

Sigachi Industries Ltd, Gensol Engineering Ltd, Balaji Telefilms Ltd and GSS Infotech Ltd ...

Read more

04 Mar 2024 14:45

News

Lotus Eye Hospital & Institute announces board meeting date

Lotus Eye Hospital & Institute will hold a meeting of the Board of Directors of the Compan...

Read more

25 Jan 2024 12:59

SWOT Analysis Of Lotus Eye Hospital & Institute Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Dr Lal Pathlabs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Lotus Eye Hospital & Institute Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Lal Pathlabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Lal Pathlabs Ltd and Lotus Eye Hospital & Institute Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or Lotus Eye Hospital & Institute Ltd?

Market cap of Dr Lal Pathlabs Ltd is 23,818 Cr while Market cap of Lotus Eye Hospital & Institute Ltd is 148 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and Lotus Eye Hospital & Institute Ltd?

The stock performance of Dr Lal Pathlabs Ltd and Lotus Eye Hospital & Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and Lotus Eye Hospital & Institute Ltd?

As of June 6, 2025, the Dr Lal Pathlabs Ltd stock price is INR ₹2849.35. On the other hand, Lotus Eye Hospital & Institute Ltd stock price is INR ₹71.47.

How do dividend payouts of Dr Lal Pathlabs Ltd and Lotus Eye Hospital & Institute Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and Lotus Eye Hospital & Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions